PhD in chemistry awarded at the University of Florence, Italy, in 2010. Since 2013 working in the field of vaccines as a scientist and senior scientist, focusing his research on the development of vaccines against neglected diseases (e.g., Salmonella Typhi, Salmonella Paratyphi A, non-typhoidal Salmonella, Shigella, Group A Streptococcus, and klebsiella pneumonia) in GSK Vaccines Institute for Global Health (GVGH, Siena, Italy). The expertise is related to the synthesis, purification, and characterization of glycoconjugates and outer membrane vesicles (OMV), investigating different platforms and innovative technologies applied to glycoconjugation, Generalised Modules for Membrane Antigens (GMMA), Multiple Antigen-Presenting Systems (MAPS) and recombinant protein.